BANGKOK (The Nation/Asia News Network): Thailand’s Food and Drug Administration (FDA) will meet on Friday, Feb. 4, to consider approving the use of Sinovac Covid-19 vaccines for children aged three and older, a FDA Secretary General Dr. Paisan Dankhum said Wednesday.
“The Sinovac vaccine to be used for children is the same type that was given to adults, and will also be given at the same amount of 0.5 cc per recipient,” he said.
“The vaccine manufacturer has submitted all required documents for approval, which include information on the age range of recipients, quantity, efficacy, side effects and other safety issues,” said Peasant.
“Once approved, Sinovac will become another vaccine choice for parents to choose from for their children. However, the decision whether or not to vaccinate a toddler should always be made by a pediatrician,” Paisan added.
So far, the Thai FDA has only approved the special orange-capped Pfizer vaccine for children over the age of five.
The FDA has also advised children between the ages of 5 and 11 who have underlying health conditions and are therefore at high risk of developing severe symptoms if they contract Covid-19 to get vaccinated first, and asked schools in high infection areas to prioritize vaccinations accordingly.